Owens & Minor (OMI) Stock Rating Reaffirmed by J P Morgan Chase & Co

Owens & Minor (NYSE:OMI)‘s stock had its “underweight” rating restated by J P Morgan Chase & Co in a research note issued on Tuesday. They presently have a $22.00 price target on the stock. J P Morgan Chase & Co’s price target indicates a potential upside of 13.11% from the company’s previous close.

Several other brokerages have also weighed in on OMI. Zacks Investment Research lowered Owens & Minor from a “hold” rating to a “sell” rating in a report on Thursday, October 12th. Leerink Swann restated a “market perform” rating and set a $23.00 target price (down previously from $34.00) on shares of Owens & Minor in a research report on Thursday, November 2nd. Robert W. Baird upgraded Owens & Minor from an “underperform” rating to a “neutral” rating and set a $28.00 target price on the stock in a research report on Friday, September 1st. Finally, Credit Suisse Group restated an “underperform” rating and set a $17.00 target price (down previously from $31.00) on shares of Owens & Minor in a research report on Monday, November 20th. Four research analysts have rated the stock with a sell rating and four have given a hold rating to the company. Owens & Minor has a consensus rating of “Hold” and an average price target of $26.50.

Owens & Minor (NYSE OMI) opened at $19.45 on Tuesday. Owens & Minor has a twelve month low of $17.75 and a twelve month high of $37.02. The firm has a market capitalization of $1,188.24, a price-to-earnings ratio of 11.02, a price-to-earnings-growth ratio of 2.09 and a beta of 0.87. The company has a current ratio of 1.77, a quick ratio of 0.95 and a debt-to-equity ratio of 0.91.

Owens & Minor (NYSE:OMI) last announced its quarterly earnings data on Wednesday, November 1st. The company reported $0.40 earnings per share for the quarter, missing the consensus estimate of $0.50 by ($0.10). Owens & Minor had a net margin of 0.83% and a return on equity of 10.85%. The firm had revenue of $2.33 billion for the quarter, compared to the consensus estimate of $2.40 billion. During the same period last year, the company posted $0.51 earnings per share. Owens & Minor’s revenue for the quarter was down 3.4% on a year-over-year basis. equities research analysts predict that Owens & Minor will post 1.77 EPS for the current year.

Large investors have recently bought and sold shares of the business. Eqis Capital Management Inc. lifted its position in shares of Owens & Minor by 141.5% during the third quarter. Eqis Capital Management Inc. now owns 18,184 shares of the company’s stock worth $531,000 after acquiring an additional 10,653 shares in the last quarter. Old Mutual Global Investors UK Ltd. purchased a new stake in shares of Owens & Minor during the third quarter worth $899,000. Dean Capital Management lifted its position in shares of Owens & Minor by 100.8% during the second quarter. Dean Capital Management now owns 132,465 shares of the company’s stock worth $4,264,000 after acquiring an additional 66,485 shares in the last quarter. Cipher Capital LP lifted its position in shares of Owens & Minor by 27.5% during the second quarter. Cipher Capital LP now owns 164,224 shares of the company’s stock worth $5,287,000 after acquiring an additional 35,378 shares in the last quarter. Finally, Caxton Associates LP purchased a new stake in shares of Owens & Minor during the second quarter worth $596,000. Hedge funds and other institutional investors own 97.68% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Owens & Minor (OMI) Stock Rating Reaffirmed by J P Morgan Chase & Co” was published by Community Financial News and is the property of of Community Financial News. If you are viewing this story on another domain, it was stolen and republished in violation of United States and international copyright law. The original version of this story can be accessed at https://www.com-unik.info/2017/12/21/owens-minor-omi-stock-rating-reaffirmed-by-j-p-morgan-chase-co.html.

About Owens & Minor

Owens & Minor, Inc is a healthcare services company that connects the world of medical products to the point of care. The Company provides supply chain assistance to the providers of healthcare services and the manufacturers of healthcare products, supplies and devices. The Company’s segments include Domestic, International and Clinical & Procedural Solutions (CPS).

Analyst Recommendations for Owens & Minor (NYSE:OMI)

Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit